How Pharmacist Licensing Board Complaints Work in Delaware (and How to Defend Your License)
A clear, supportive guide to understanding the complaint process with the Delaware Board of Pharmacy and protecting your professional license
What do you need help with?
Choose the situation that best matches what you're experiencing.
Select your situation, profession, and state to continue.
If you've received notice of a complaint filed with the Delaware Board of Pharmacy, you're likely feeling anxious, confused, or even scared. That's completely understandable. A licensing board complaint can feel like a threat to everything you've worked for.
Here's what's important to know: receiving a complaint doesn't mean you've done anything wrong. Many complaints are administrative in nature, stem from misunderstandings, or are resolved without any disciplinary action.
This guide will walk you through what to expect, help you understand the process, and give you the clarity you need to respond thoughtfully. It also explains early, practical steps professionals use to begin defending themselves and protecting their license. You're not alone in this.
If you received a written notice from a board investigator, you may also want to review our guide on responding to licensing board investigation letters. Understanding how the investigation process works can also help you prepare.
What Triggers Complaints Against Pharmacists in Delaware
Administrative Issues
These are often paperwork or compliance matters that can typically be resolved without formal discipline.
- Failure to renew the Delaware pharmacist license biennially through the Division of Professional Regulation (DPR) online portal
- Continuing education deficiencies (30 hours per biennial renewal under 24 Del. Admin. Code 2500, including required ACPE topics)
- Pharmacy permit deficiencies or late notification of changes in ownership, location, or pharmacist-in-charge (PIC)
- Failure to maintain accurate controlled substance inventories, biennial inventory, or DEA Form 222 records
Conduct-Related Concerns
These involve clinical practice or professional behavior and require careful, thoughtful responses.
- Dispensing errors, wrong drug, wrong strength, wrong directions, particularly those resulting in patient harm
- Controlled substance diversion, theft, or failure to perform corresponding responsibility for opioid prescriptions
- Failure to query the Delaware Prescription Monitoring Program (PMP) before dispensing opioids or benzodiazepines (16 Del. C. § 4798)
- Practicing while impaired by drugs, alcohol, or untreated mental health conditions
- Failure to perform required Drug Utilization Review (DUR) or patient counseling under 24 Del. Admin. Code 2500
- Compounding violations, including USP 797/800 sterile compounding standards
- Fraud, theft, or felony conviction (mandatory self-report within 30 days)
What Happens After a Complaint Is Filed with the Delaware Board of Pharmacy
Understanding the process can help reduce anxiety and prepare you for each step.
Complaint Filed
The Division of Professional Regulation receives complaints from patients, prescribers, pharmacy benefit managers, employers, law enforcement, or other licensees. Complaints can be filed online or by mail.
Initial Assessment
DPR Investigative Services Unit reviews the complaint to confirm jurisdiction under 24 Del. C. Chapter 25 and to evaluate whether the allegations, if proven, would constitute a violation.
Investigation
A DPR investigator gathers evidence including dispensing records, PMP reports, perpetual inventories, DEA records, surveillance footage, and witness statements. The Board may also issue subpoenas.
Response Opportunity
The pharmacist receives a written notice and is invited to submit a written response, commonly within 20–30 days.
Board Review
The Board of Pharmacy reviews the investigative file and the licensee's response in executive session to decide whether to dismiss, issue a Letter of Concern, negotiate a Consent Agreement, or file formal charges.
Hearing and Final Order
Formal hearings are conducted before the Board under Delaware's Administrative Procedures Act (29 Del. C. Chapter 101). The Board issues the final order, which is appealable to the Superior Court within 30 days.
Note: This process overview is based on typical procedures under Delaware Code, Title 24, Chapter 25. Your specific case may vary.
Begin protecting your license and organizing your response.
Responding to the Delaware Board of Pharmacy
Response Deadline
The Delaware Board of Pharmacy often specifies a response deadline (commonly around 30 days), but the exact timeframe varies by case. Check your specific notice for the deadline.
Possible Outcomes
Outcomes vary significantly based on the nature of the complaint, the evidence, and how you respond. Here are typical possibilities:
Case Closure / Dismissal
No violation substantiated; case closed without action.
Letter of Concern
Non-disciplinary advisory letter; not reported to NPDB but retained in Board file.
Consent Agreement
Negotiated public order with terms such as CE, audits, restricted practice, fines, or monitoring.
Probation
License remains active subject to specific conditions and reporting requirements.
Fine
Civil penalty up to $5,000 per violation under 24 Del. C. § 2518.
Suspension
Temporary loss of license, including potential summary suspension for imminent public danger.
Revocation
Permanent loss of Delaware pharmacist license; reapplication requires Board petition.
Every case is unique. These outcomes are general possibilities, not predictions about your specific situation.
Your case details stay private, by design
BoardWise uses Zero Sensitive Data Retention. Your documents, answers, and drafts are processed on your device and are never stored on our servers.
BoardWise keeps your sensitive case details isolated on your device from start to finish.
Not Ready to Sign Up Yet?
Take our free calming checklist for responding to the Board; it'll help you stay grounded and organized.
The Delaware Board of Pharmacy Process
The Delaware Board of Pharmacy regulates pharmacists and pharmacy technicians under Delaware Code Title 24, Chapter 25. The Board operates under the Division of Professional Regulation within the Department of State. Investigations are conducted by Division investigators.
What Makes This Process Unique
Delaware uses the Division of Professional Regulation centralized model for investigations.
Delaware's PDMP requires pharmacists to check before dispensing opioids and benzodiazepines.
The Board may issue Letters of Concern as non-disciplinary advisories.
Consent Agreements are the primary negotiated resolution.
Delaware requires 30 hours of CE per biennial renewal.
Tips for Responding
- Respond to the Division's investigation notice within the stated deadline, commonly around 30 days.
- Ensure PDMP compliance for all opioid and benzodiazepine dispensing.
- If offered a Consent Agreement, have an attorney review all terms. Many professionals view this stage as a key part of their overall license defense strategy.
- Document dispensing procedures, quality assurance protocols, and patient counseling practices.
- Legal representation is recommended for controlled substance allegations.
